A new measure of between-studies heterogeneity in meta-analysis

被引:32
作者
Crippa, Alessio [1 ]
Khudyakov, Polyna [2 ]
Wang, Molin [2 ,3 ]
Orsini, Nicola [1 ]
Spiegelman, Donna [2 ,3 ,4 ]
机构
[1] Karolinska Inst, Dept Publ Hlth Sci, Tomtebodavagen 18A, S-17177 Stockholm, Sweden
[2] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA
[4] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
关键词
heterogeneity; meta-analysis; random-effects; RANDOM-EFFECTS MODEL; VARIANCE ESTIMATORS; CLINICAL-TRIALS;
D O I
10.1002/sim.6980
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Assessing the magnitude of heterogeneity in a meta-analysis is important for determining the appropriateness of combining results. The most popular measure of heterogeneity, I-2, was derived under an assumption of homogeneity of the within-study variances, which is almost never true, and the alternative estimator, I, uses the harmonic mean to estimate the average of the within-study variances, which may also lead to bias. This paper thus presents a new measure for quantifying the extent to which the variance of the pooled random-effects estimator is due to between-studies variation, b, that overcomes the limitations of the previous approach. We show that this measure estimates the expected value of the proportion of total variance due to between-studies variation and we present its point and interval estimators. The performance of all three heterogeneity measures is evaluated in an extensive simulation study. A negative bias for b was observed when the number of studies was very small and became negligible as the number of studies increased, while I and I-2 showed a tendency to overestimate the impact of heterogeneity. The coverage of confidence intervals based upon b was good across different simulation scenarios but was substantially lower for I and I-2, especially for high values of heterogeneity and when a large number of studies were included in the meta-analysis. The proposed measure is implemented in a user-friendly function available for routine use in r and sas. b will be useful in quantifying the magnitude of heterogeneity in meta-analysis and should supplement the p-value for the test of heterogeneity obtained from the Q test. Copyright (c) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:3661 / 3675
页数:15
相关论文
共 19 条
[1]  
Biggerstaff BJ, 1997, STAT MED, V16, P753, DOI 10.1002/(SICI)1097-0258(19970415)16:7<753::AID-SIM494>3.3.CO
[2]  
2-7
[3]   THE COMBINATION OF ESTIMATES FROM DIFFERENT EXPERIMENTS [J].
COCHRAN, WG .
BIOMETRICS, 1954, 10 (01) :101-129
[4]   HETEROGENEITY IN METAANALYSIS OF DATA FROM EPIDEMIOLOGIC STUDIES - COMMENTARY [J].
COLDITZ, GA ;
BURDICK, E ;
MOSTELLER, F .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (04) :371-382
[5]   EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE [J].
COLDITZ, GA ;
BREWER, TF ;
BERKEY, CS ;
WILSON, ME ;
BURDICK, E ;
FINEBERG, HV ;
MOSTELLER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :698-702
[6]  
Crippa A, 2014, DOSRESMETA PERFORMIN
[7]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[8]   Random-effects model for meta-analysis of clinical trials: An update [J].
DerSimonian, Rebecca ;
Kacker, Raghu .
CONTEMPORARY CLINICAL TRIALS, 2007, 28 (02) :105-114
[9]  
Gibson P.G., 2003, Cochrane Database of Systematic Reviews
[10]  
Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO